Applications


  • Diagnostics
    Timely PCR-based diagnostics for viral nucleic acid detection and mass spectrometry for viral peptide detection have been developed. Learn more about the tools and techniques used for oligonucleotide and peptide analysis.
    Read Application Notes
  • Small Molecule Drugs
    Many small molecules are being examined for their ability to inhibit the replication and transmission of SARS-CoV-2. Find more resources related to these small molecule drug applications.
    Read Application Notes
  • Protein-Based Vaccines
    Protein-based vaccines have emerged as a promising therapy to combat COVID-19. Learn more about the tools and techniques for protein-based vaccine analysis.
    Read Application Notes


Frequently Asked Questions

How have you adjusted your business continuity plans?

We have an Enterprise Risk Management Framework in place to address our key risks as a global enterprise in the following focus areas: strategic, operational, compliance, and financial.

What does this mean for your global supply chain?

Our global supply chain team continues to work closely with our supply base across the world to mitigate potential risks and place expedited orders for items with extended lead times.

How has COVID affected logistics?

Our global logistics team is working closely with transportation providers to put action plans in place to minimize disruption to our distribution network.

Who do I contact if I have a service need?

The best method to alert us of your service needs and to access our remote or onsite support options is through our support Resources Hub.

For Waters customers, please visit waters.com/success

For TA customers, please visit tainstruments.com/support

What if I need on-site service?

We continue to provide on-site service where local laws and regulations permit. Please note that service visits are being prioritized based on criticality of needs.

For Waters customers, please visit waters.com/success

For TA customers, please visit tainstruments.com/support



Messages from Our Leadership

Read the latest message from our CEO sharing an update on the rapid response of our COVID-19 Innovation Response Team deploying expertise and technology to the scientific front line of the outbreak, from treatment research to vaccine development and beyond.


For any additional questions or support inquiries, please contact us. 

For any additional questions or support inquiries, please contact us. 
Back To Top Back To Top